SLN approach for nose-to-brain delivery of alprazolam

Drug Delivery and Translational Research

Volumn 2, Issue 6, 2012, Pages 498-507

  Singh, Alok Pratap ^a   Saraf, Shailendra K ^b   Saraf, Shubhini A ^a,c  

^a BABU BANARASI DAS NATIONAL INSTITUTE OF TECHNOLOGY AND MANAGEMENT   (India)

^b Babu Banarasi das National Institute of Technology   (India)

^c BABASAHEB BHIMRAO AMBEDKAR UNIVERSITY   (India)

Author keywords

Brain targeting; Gamma scintigraphy; Lipoidal; Nanoparticles; SLN

Indexed keywords

ALPRAZOLAM; SOLID LIPID NANOPARTICLE; TECHNETIUM 99M;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG FORMULATION; ENCAPSULATION; GAMMA SCINTIGRAPHY; MALE; NONHUMAN; NOSE TO BRAIN DRUG DELIVERY; PRIORITY JOURNAL; RABBIT; RADIOACTIVITY; RAT;

EID: 84869044646     PISSN: 2190393X     EISSN: 21903948     Source Type: Journal    
DOI: 10.1007/s13346-012-0110-2     Document Type: Article

References (28)

1. Mishra AN, Shah SP. Drug delivery to the central nervous system: a review. J Pharm Pharm Sci. 2003; 6(2): 252-73.
2. Blasi P, Giovagnoli S, Schoubben A, Ricci M, Rossi C. Solid lipid nanoparticles for targeted brain delivery. Adv Drug Deliv Rev. 2007; 59: 454-77.
3. Tripathi KD. Essentials of medical pharmacology. 6th ed. New Delhi: Jay Pee Brothers Medical; 2008. p. 449-51.
4. Sweetman SC. Martindale: The Complete Drug Reference. 33rd ed. London: The Pharmaceutical Press; 2002. p. 960.
5. Mygind N, Dahl R. Anatomy, physiology and function of the nasal cavities in health and disease. Adv Drug Deliv Rev. 1998; 29: 3-12.
6. Illum L. Nasal drug delivery: new developments and strategies. Drug Discov Today. 2002; 7(23): 1184-9.
7. Mitra AK, Krishnamoorthy R. Prodrugs for nasal drug delivery. Adv Drug Deliv Rev. 1998; 29: 135-46.
8. Kaur IP, Bhandari R, Bhandari S, Kakkar V. Potential of solid lipid nanoparticles in brain targeting. J Control Release. 2008; 127: 97-109.
9. Mukherjee S, Ray S, Thakur RS. Design and evaluation of itraconazole loaded solid lipid nanoparticulate system for improving the antifungal therapy. Pak J Pharm Sci. 2009; 22(2): 131-8.
10. Bhaskar K, Anbu J, Ravichandiran V, Venkateswarlu V, Rao YM. Lipid nanoparticles for transdermal delivery of flurbiprofen: formulation, in vitro, ex vivo and in vivo studies. Lipids Health Dis. 2009; 8(1): 1-15.
11. Lewis GA. Optimization methods. In: Swarbrick J, editor. Encyclopedia of pharmaceutical technology, vol. 4. 3rd ed. New York: The Informa Health Care; 2007. p. 2452-67.
12. Huang G, Zhang N, Bi X, Dou M. Solid lipid nanoparticles of temozolomide: potential reduction of cardial and nephric toxicity. Int J Pharm. 2008; 355(1-2): 314-20.
13. Jores K, Mehnert W, Drechsler M, Bunjes H, Johann C, Mader K. Investigations on the structure of solid lipid nanoparticles (SLN) and oil-loaded solid lipid nanoparticles by photon correlation spectroscopy, field-flow fractionation and transmission electron microscopy. J Control Release. 2004; 95(2): 217-27.
14. USP 23/NF-18, United States Pharmacopeial Convention, Rockville, MD; 1995. p. 65.
15. Zhang X, Miao J, Li M, Jiang S, Hu F, Du Y. Solid lipid nanoparticles loading adefovir dipivoxil for antiviral therapy. J Zhejiang Univ (Sci B). 2008; 9(6): 506-10.
16. Chen DB, Yang TZ, Lu WL, Zhang O. In vitro and in vivo study of two types of long-circulating solid lipid nanoparticles containing paclitaxel. Chem Pharm Bull. 2001; 49: 1444-7.
17. 99mTc labeled Photosan-3, a heamatoporphyrin derivative, as a potential radiopharmaceutical for tumor scintigraphy. Nucl Med Biol. 2000; 27: 419-26.
18. Saha GB. Methods of radiolabeling. Physics and radiobiology of nuclear medicine. New York: Springer; 1993. p. 100-6.
19. Zhang Q, Jiang X, Jiang W, Lu W, Su L, Shi Z. Preparation of nimodipine-loaded microemulsion for intranasal delivery and evaluation on the targeting efficiency to the brain. Int J Pharm. 2004; 275(1-2): 85-96.
20. Pandita D, Ahuja A, Velpandian T, Lather V, Dutta T, Khar RK. Characterization and in vitro assessment of paclitaxel loaded lipid nanoparticles formulated using modified solvent injection technique. Pharmazie. 2009; 64: 301-10.
21. Trotta M, Debernardi F, Caputo O. Preparation of solid lipid nanoparticles by a solvent emulsification-diffusion technique. Int J Pharm. 2003; 257: 153-60.
22. Costa P, Lobo JMS. Modeling and comparison of dissolution profiles. Eur J Pharm Sci. 2001; 13: 123-33.
23. Shoaib MH, Tazeen T, Merchant HA, Yousuf RI. Evaluation of drug release kinetics from ibuprofen matrix tablets using HPMC. Pak J Pharm Sci. 2006; 19(2): 119-24.
24. Malinoeski HJ, Johnson SB. Bioavailability and bioequivalency testing. In: Gennaro AR, editor. Remington: The science and practice of pharmacy, 21st ed. New Delhi: Wolters Kluwer; 2006. 1: 1037-46.
25. Mader K, Mehnert W. Solid lipid nanoparticles: production, characterization and applications. Adv Drug Deliv Rev. 2001; 47: 165-96.
26. Illum L. Nasal drug delivery-possibilities, problems and solutions. J Control Release. 2003; 87(1-3): 187-98.
27. Mistry A, Stolnik S, Illum L. Nanoparticles for direct nose-to-brain delivery of drugs. Int J Pharm. 2009; 379(1): 146-57.
28. Illum L. Transport of drugs from the nasal cavity to the central nervous system. Eur J Pharm Sci. 2000; 11(1): 1-18.